Skip to main content

news

 

Khaitan & Co has guided India’s second-largest healthcare provider, Manipal Hospitals, on its $168 million acquisition of an 87 percent stake in Kolkata-based hospital chain Medica Synergie from Sheares Healthcare, who were advised by J. Sagar Associates.

The acquisition is in line with Bengaluru-based Manipal Hospitals' strategy of expanding its footprint and presence in Eastern India as the leading hospital chain in the region, the company said in a press release.

The Khaitan team on the deal was led by partners Bharat Anand and Aditya Patni and included counsel Kevin Peter, principal associate Vishakha Singh, senior associate Tushar Bakshi and associate Priyanka Priyadarshini.

Partners Abhinav Rastogi (employment), Gaurav Dasgupta (real estate), Pranjal Prateek (antitrust) and Sachin Bhandawat (trusts) assisted with their subject matter expertise.

The JSA team advising sellers Sheares Healthcare was led by partners Vikram Raghani and Varun Sehgal, and included of counsel Yashvi Singh, and associates Vaishnavi Vyas and Darshin Pareekh. 

 

TO CONTACT EDITORIAL TEAM, PLEASE EMAIL ALBEDITOR@THOMSONREUTERS.COM

Related Articles

Deals

Khaitan, JSA, Hogan Lovells guide $515 mln Waaree IPO

by Nimitt Dixit |

Khaitan & Co has advised Waaree Energies, India's largest manufacturer and exporter of solar modules, on its $515 million initial public offering, with JSA Advocates & Solicitors and Hogan Lovells guiding the bookrunning lead managers.

Deals

CAM, Khaitan guide Adani-backed Renew Exim’s $380 mln ITD acquisition

by Nimitt Dixit |

Cyril Amarchand Mangaldas has advised Adani Group's Dubai-based firm Renew Exim DMCC on its acquisition of a 46.64 percent stake in ITD Cementation India for around $380 million from Italian-Thai Development Public Company, who was represented by Khaitan & Co.

Deals

CAM, AZB, SAM, Latham advise on landmark $1.3 bln Swiggy IPO

by Nimitt Dixit |

Cyril Amarchand Mangaldas is advising SoftBank-backed Indian food and grocery delivery giant Swiggy on its much-anticipated initial public offering worth $1.3 billion, with AZB & Partners and Latham & Watkins advising the bookrunning lead managers.